CORC

在结果中检索

CORC

浏览/检索结果: 共42条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Synergistic efficacy of the demethylation agent decitabine in combination with the protease inhibitor bortezomib for treating multiple myeloma through the Wnt/βcatenin pathway. 期刊论文
Oncology research, 2019
作者:  Yulong Jin;  Li Xu;  Xiaodong Wu;  Juan Feng;  Mimi Shu
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/17
国产甲磺酸伊马替尼治疗初诊慢性髓系白血病慢性期的临床研究 期刊论文
临床血液学杂志, 2018, 期号: 11
作者:  马军;  罗建民;  闻艳;  曹志坚;  李书芹
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/04
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study 期刊论文
CANCER MEDICINE, 2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:  Huang, Xiaojun;  Qiu, Lugui;  Jin, Jie;  Zhou, Daobin;  Chen, Xiequn
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study 期刊论文
2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:  Huang, Xiaojun;  Qiu, Lugui;  Jin, Jie;  Zhou, Daobin;  Chen, Xiequn
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 会议论文
BLOOD, 2018-11-29
作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 期刊论文
2018, 卷号: 132
作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Enhanced recovery after surgery for pancreaticoduodenectomy: Review of current evidence and trends 期刊论文
2018, 卷号: 50, 页码: 79-86
作者:  Xu, Xiequn;  Zheng, Chaoji;  Zhao, Yupei;  Chen, Weiyun;  Huang, Yuguang
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu;  Liu, Ting
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Liu, Peng;  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study 期刊论文
Journal of Hematology & Oncology, 2017, 卷号: 10, 期号: 1, 页码: 137
作者:  Hou, Jian*;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/03

©版权所有 ©2017 CSpace - Powered by CSpace